Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma

Int J Infect Dis. 2010 Mar;14(3):e265-6. doi: 10.1016/j.ijid.2009.04.014. Epub 2009 Aug 7.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antiviral Agents / therapeutic use*
  • Chemoprevention
  • Cyclophosphamide
  • Doxorubicin / analogs & derivatives
  • Female
  • Guanine / analogs & derivatives*
  • Guanine / therapeutic use
  • Hepatitis B / prevention & control
  • Hepatitis B / virology
  • Hepatitis B virus / drug effects*
  • Hepatitis B virus / physiology
  • Humans
  • Lymphoma / complications*
  • Lymphoma / drug therapy
  • Male
  • Middle Aged
  • Prednisone
  • Treatment Outcome
  • Vincristine
  • Virus Activation / drug effects*

Substances

  • Antiviral Agents
  • entecavir
  • Vincristine
  • Guanine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol, modified